Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Pierce

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nurse Educator|July 19, 2021
Developing Cultural Humility Among Prelicensure Nursing StudentsAshley Carter, Shellye Davis, Amy Pierce, et al.
FEBS Letters|February 16, 2007
Neurogenin 3 recruits CBP co-activator to facilitate histone H3/H4 acetylation in the target gene INSM1Mary B Breslin, Hong-Wei Wang, Amy Pierce, et al.
Journal of Cell Science|November 23, 2007
MAP-kinase activity necessary for TGFbeta1-stimulated mesangial cell type I collagen expression requires adhesion-dependent phosphorylation of FAK tyrosine 397Tomoko Hayashida, Ming-Hua Wu, Amy Pierce, et al.
Infection Control and Hospital Epidemiology|October 20, 2020
Healthcare-associated outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a rural hospital in Missouri, March 2020George Turabelidze, Betty C Faulconer, Steven J Lawrence, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2020
Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense® Entry assayMargaret Gartland, Nannan Zhou, Eugene Stewart, et al.
Open Forum Infectious Diseases|September 5, 2024
Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE StudyAndrew Clark, Manyu Prakash, Shiven Chabria, et al.
Journal of Pediatric Surgery|September 3, 2025
Same Day Discharge Following Minimally Invasive Repair of Pectus ExcavatumCory Nonnemacher, Seth Saylors, Meredith Elman, et al.
Pain|January 1, 2008
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer painLynn Webster, Jan Peter Jansen, John Peppin, et al.
The Journal of Supportive Oncology|June 18, 2010
Enhancing enrollment in palliative care trials: key insights from a randomized, placebo-controlled studyAmy P Abernethy, David C Currow, John Wurzelmann, et al.
The Journal of Pain|February 5, 2011
A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer painJan-Peter Jansen, Daniel Lorch, John Langan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nurse Educator|July 19, 2021
Developing Cultural Humility Among Prelicensure Nursing StudentsAshley Carter, Shellye Davis, Amy Pierce, et al.
FEBS Letters|February 16, 2007
Neurogenin 3 recruits CBP co-activator to facilitate histone H3/H4 acetylation in the target gene INSM1Mary B Breslin, Hong-Wei Wang, Amy Pierce, et al.
Journal of Cell Science|November 23, 2007
MAP-kinase activity necessary for TGFbeta1-stimulated mesangial cell type I collagen expression requires adhesion-dependent phosphorylation of FAK tyrosine 397Tomoko Hayashida, Ming-Hua Wu, Amy Pierce, et al.
Infection Control and Hospital Epidemiology|October 20, 2020
Healthcare-associated outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a rural hospital in Missouri, March 2020George Turabelidze, Betty C Faulconer, Steven J Lawrence, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2020
Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense® Entry assayMargaret Gartland, Nannan Zhou, Eugene Stewart, et al.
Open Forum Infectious Diseases|September 5, 2024
Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE StudyAndrew Clark, Manyu Prakash, Shiven Chabria, et al.
Journal of Pediatric Surgery|September 3, 2025
Same Day Discharge Following Minimally Invasive Repair of Pectus ExcavatumCory Nonnemacher, Seth Saylors, Meredith Elman, et al.
Pain|January 1, 2008
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer painLynn Webster, Jan Peter Jansen, John Peppin, et al.
The Journal of Supportive Oncology|June 18, 2010
Enhancing enrollment in palliative care trials: key insights from a randomized, placebo-controlled studyAmy P Abernethy, David C Currow, John Wurzelmann, et al.
The Journal of Pain|February 5, 2011
A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer painJan-Peter Jansen, Daniel Lorch, John Langan, et al.
Pageof 3